TET2 and acute myeloid leukemia: Several previous studies have reported that genetic variants in the TET2 gene are involved in development of hematological malignancies including AML (Duployez et al., 2020; Feng et al., 2019; Zeng et al., 2019; Weissmann et al., 2012).